Division of Endocrinology, Diabetes & Metabolism, UCLA David Geffen School of Medicine, 200 Medical Plaza Driveway #530, Los Angeles, CA 90095, USA.
Department of Imaging, Cedars-Sinai Medical Center, 8700 Beverly Boulevard #M335, Los Angeles, CA 90048, USA.
Endocrinol Metab Clin North Am. 2017 Sep;46(3):795-814. doi: 10.1016/j.ecl.2017.04.008. Epub 2017 Jun 20.
Imaging is critical in the diagnosis, prognosis, and management of neuroendocrine tumors (NETs). NETs share common imaging features, but each type exhibits unique features. Computed tomography scans or MRI of the abdomen is used to assess tumor burden routinely. Functional imaging with octreotide scan or gallium-68 somatostatin analog PET is used selectively to confirm diagnosis and guide therapy. Clinicians and radiologists should be familiar with the indications and interpretations of imaging modalities. Novel functional imaging modalities likely will be developed to detect small NETs, predict prognosis, guide therapeutic choices, and design novel therapies.
影像学检查在神经内分泌肿瘤（NETs）的诊断、预后和治疗管理中至关重要。NETs 具有共同的影像学特征，但每种类型都具有独特的特征。腹部计算机断层扫描或磁共振成像用于常规评估肿瘤负荷。奥曲肽扫描或镓-68 生长抑素类似物 PET 的功能成像用于选择性确认诊断和指导治疗。临床医生和放射科医生应熟悉影像学检查的适应证和解读。新型的功能影像学检查方法可能会被开发出来，以检测小的 NETs、预测预后、指导治疗选择和设计新的治疗方法。
